| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/02/2008 | CN100378087C Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 04/02/2008 | CN100378054C Process for preparation of 3,3-dimethylbutanal |
| 04/01/2008 | USRE40198 Method and device for electrochemical immunoassay of multiple analytes |
| 04/01/2008 | US7351840 Perindopril |
| 04/01/2008 | US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 04/01/2008 | US7351690 Knockout identification of target-specific sites in peptides |
| 03/27/2008 | WO2008034575A1 Iminosugar glycoconjugates |
| 03/27/2008 | WO2004069200A3 Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
| 03/27/2008 | WO2003075845A3 Immunogenicity of glucan binding protein |
| 03/27/2008 | US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/27/2008 | US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
| 03/27/2008 | US20080076752 substituted structure of 3-amino-2-(2,5-difluorophenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one; 6-amino-7-phenyl-1,4-thiazepan-5-one; -amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one for treating neurological disorders such as Alzheimer's; inhibit the production of amyloid beta protein |
| 03/27/2008 | US20080076718 oligopeptide or polypeptide amino acid sequences as biodrug antitumor agents, anticarcinogenic agents; treating autoimmune diseases, AIDS, inflammatory diseases, cardiovascular disorder of ischemic processes, allograft rejection, cerebral strokes, traumas, burns, Alzheimer's disease, Parkinson's disease |
| 03/26/2008 | EP1903053A1 Elastin production-enhancing agents |
| 03/26/2008 | EP1903052A2 APJ receptor ligands and uses thereof |
| 03/26/2008 | EP1903033A1 Coniosetine, process for preparation and use as pharmaceutical |
| 03/26/2008 | EP1902065A2 Cyclic amide derivatives inhibitors of the inhibitor of apoptosis proteins, their preparation, and their use |
| 03/26/2008 | EP1901761A2 Thrombospondin-1 derived peptides and treatment methods |
| 03/26/2008 | EP1901751A1 Alpha-helix mimetics and methods relating to the treatment of fibrosis |
| 03/26/2008 | EP1701974B1 Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments |
| 03/26/2008 | EP1641754B1 Process and intermediates for the preparation of (1r, 2s, 5s)-3- azabicyclo[ 3, 1, 0]hexane-2-carboxamide, n- [3-amino -1-(cyclobutylmethyl)-2, 3-dioxopropyl] ]-3- [ (2s)- 2-[[[1, 1-dimethylethyl ]amino]carbonyla mino ]-3, 3-dimethyl-1-oxobutyl] -6, 6-dimethyl |
| 03/26/2008 | EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/26/2008 | EP0923553B1 Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl compounds |
| 03/26/2008 | CN101151369A Dipeptide crystals and process for production thereof |
| 03/26/2008 | CN100376570C Dioxolane analogs for improved inter-cellular delivery |
| 03/25/2008 | US7348459 Reacting isobutylene, ethylene and mineral acid; hydrolyzing the ester to produce 3,3-dimethylbutanol, and converting 3,3-dimethylbutanol to 3,3-dimethylbutanal; by-product inhibition |
| 03/25/2008 | US7348404 Solid-phase peptide synthesis and agent for use in such synthesis |
| 03/25/2008 | US7348403 Contacting a peptide with the agent under conditions permitting formation of a phosphorus-based ester; and determining whether a phosphorus-based ester has formed between the peptide and the agent; inactivation of organophosphorus-based insecticides and chemical warfare agents |
| 03/25/2008 | US7348311 Derivatives of dehydrodidemnin B |
| 03/25/2008 | US7348310 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 03/25/2008 | US7348307 Treating Non-Hodgkins lymphoma by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 03/25/2008 | US7347998 Method of delivering therapeutic agents to site of tissue injury |
| 03/25/2008 | CA2385533C Polymer stabilized neuropeptides |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/20/2008 | WO2008033557A2 Click chemistry-derived cyclic peptidomimetics as integrin markers |
| 03/20/2008 | WO2008033389A2 Macrocyclic hcv inhibitors and their uses |
| 03/20/2008 | WO2008033328A2 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| 03/20/2008 | WO2007103739A3 Methods and compositions related to cyclic peptide synthesis |
| 03/20/2008 | WO2007095259A3 Antimycotic rhamnolipid compositions and related methods of use |
| 03/20/2008 | US20080071706 Method of designing high-affinity peptide, method of preparing high-affinity peptides, computer-readable storage medium storing a program for designing high-affinity peptide, apparatus for designing high-affinity peptide, and high-affinity peptide |
| 03/20/2008 | US20080070953 Inhibitors of interleukin-1 beta converting enzyme |
| 03/20/2008 | US20080070843 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 03/20/2008 | CA2663159A1 Organic compounds and their uses |
| 03/20/2008 | CA2662897A1 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| 03/19/2008 | EP1901069A1 Fret protease assays for clostridial toxins |
| 03/19/2008 | EP1900747A1 Compound having photosensitization activity, photoelectrode, and photosensitization-type solar cell |
| 03/19/2008 | EP1900367A2 Hypoglycemic agent |
| 03/19/2008 | EP1900366A2 Hypoglycemic agent |
| 03/19/2008 | EP1899365A2 Angiotensin i-converting enzyme (ace) inhibitors |
| 03/19/2008 | EP1575991A4 Peptides comprising aromatic d-amino acids and methods of use |
| 03/19/2008 | CN101146819A Peptides that increase collagen or hyaluronic acid production |
| 03/19/2008 | CN101143893A Thymus tripeptide active isomer and preparation method and medical use thereof |
| 03/19/2008 | CN101143892A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 03/19/2008 | CN101143891A Technique for separating and purifying oxidation resistance dipeptide in protamine hydrolyzate |
| 03/19/2008 | CN101143855A Method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 03/18/2008 | US7345143 Plastid transit peptides |
| 03/18/2008 | US7345081 Azabicyclo-octane inhibitors of IAP |
| 03/18/2008 | US7345022 Anti-fibril peptides |
| 03/18/2008 | US7344884 Fibronectins; fibroblast growth factors |
| 03/18/2008 | CA2189145C Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 03/13/2008 | WO2008029565A1 Compound having inhibitory activity on histone deacetylase, and pharmaceutical comprising the compound as active ingredient |
| 03/13/2008 | WO2008014263A3 Dimeric iap antagonists |
| 03/13/2008 | WO2008014252A3 Iap inhibitors |
| 03/13/2008 | US20080064676 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity |
| 03/13/2008 | US20080063585 Fullerene nanotube compositions |
| 03/13/2008 | DE102006039615A1 Esterelongationsverfahren zum sequenzgesteuerten Aufbau alternierender Peptid-Peptoid-Polymere (Peptid-Peptoid-Polymere) Esterelongationsverfahren for the sequence-structure-controlled alternating peptide-peptoid polymers (peptide-peptoid polymers) |
| 03/12/2008 | EP1897553A1 Inhibitor of stem cell proliferation and uses thereof |
| 03/12/2008 | EP1897550A2 Prodrugs of Excitatory Amino Acids |
| 03/12/2008 | EP1897541A2 Hypoglycemic agent |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896407A1 Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia |
| 03/12/2008 | EP1896047A1 Anti-gfralpha3 antibodies |
| 03/12/2008 | EP1114828B1 N-alkylaspartyldipeptide ester derivatives and sweeteners |
| 03/12/2008 | EP0973538B1 Modified proteins which bind extracellular matrix components |
| 03/12/2008 | CN101139625A Ace inhibitory peptides from plant materials |
| 03/12/2008 | CN101139383A C end modification endomorphin 2 |
| 03/12/2008 | CN101139382A Method for separating and purifying glutathione in fermentation liquor by five-region simulated moving bed chromatography |
| 03/12/2008 | CN101139381A Method for preparing reaction time controlled chirality amino acid dipeptide |
| 03/12/2008 | CN100374459C Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 03/12/2008 | CN100374456C Specific human antibodies for selective cancer therapy |
| 03/12/2008 | CN100374115C Substituted diketopiperazines as oxytocin antagonists |
| 03/11/2008 | US7342095 Peptidomimetic inhibitors of STAT activity and uses thereof |
| 03/11/2008 | US7342093 nhibitor of Apoptosis (IAP) proteins, cancer |
| 03/11/2008 | US7342092 Vaccines as dosage forms; acute myeloblastic leukemia |
| 03/11/2008 | US7342041 viricide; synergistic mixture with antiviral agent (ribavirin) and alpha - or pegylated interferon; Human Immunogeficiency Virus, Acquired Immune Deficiency Syndrome |
| 03/11/2008 | US7342007 prevent the formation of neurological deposits of amyloid protein; Alzheimer's disease, cognitive impairment; novel lactarns; N2-[(3,5-difluorophenyl)acetyl]-N1-[(3S,7S)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide; secretase inhibitors |
| 03/06/2008 | WO2007098361A3 Laminate structure suitable for furniture exteriors |
| 03/06/2008 | US20080058546 Methods for Synthesis of Acyloxyalkyl Derivatives of GABA Analogs |
| 03/06/2008 | US20080058336 Secretase inhibitor |
| 03/06/2008 | US20080057491 Atherosclerosis; thrombosis; enzyme inhibitors; drug screening |
| 03/05/2008 | EP1893643A1 Compositions and methods for preventing or treating hiv infection |
| 03/05/2008 | EP1893634A2 Pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 03/05/2008 | EP1893633A2 Angiotensin i - converting enzyme (ace) inhibitors |
| 03/05/2008 | EP0989993B1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 03/05/2008 | CN101134774A Combined chemical modified endomorphin-1 and method for preparing same |
| 03/05/2008 | CN101134773A Method for extracting corn free radical scavenger |
| 03/05/2008 | CN100372870C Polyethylene glycol derivatives of thymosin alphal |
| 03/04/2008 | US7339027 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7338780 Method for producing tripeptides and/or peptides longer than tripeptides |